The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real-world Clinical Setting-Reference-Cited by-同舟云学术

The Impact of Long-acting Paliperidone in Reducing Hospitalizations and Clinical Severity in Recent Onset Schizophrenia: A Mirror-image Study in Real-world Clinical Setting

Published:2022-02-28 Issue:1 Volume:20 Page:118-125
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Peitl Vjekoslav¹²^ORCID,Margetić Branka Aukst¹²^ORCID,Vidrih Branka¹²^ORCID,Karlović Dalibor¹²^ORCID

Affiliation:

1. Department of Psychiatry, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia

2. Catholic University of Croatia, Zagreb, Croatia

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2022/020/cpn020-01-11.pdf

Reference41 articles.

1. Karlović D, Peitl V, Silić A. Shizofrenije. Jastrebarsko:Naklada Slap;2019. Croatian.

2. Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study

3. Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

4. Antipsychotic Treatment and Mortality in Schizophrenia

5. Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults;Expert Review of Neurotherapeutics;2024-03-06

2. Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review;BMC Psychiatry;2024-01-19

3. Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis;CNS Drugs;2023-07-25

4. Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders;Molecular Psychiatry;2023-07-21

5. Psychiatric hospitalisation before and after commencing long-acting injectable antipsychotic medication: a mirror-image study;NEW ZEAL MED J;2022